American Century Companies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-27,057
Closed -$2.73M 1346
2018
Q4
$2.73M Sell
27,057
-2,435
-8% -$252K ﹤0.01% 920
2018
Q3
$3.73M Buy
+29,492
New +$3.12M ﹤0.01% 917
2016
Q1
Sell
-2,317
Closed -$346K 1385
2015
Q4
$346K Hold
2,317
﹤0.01% 1241
2015
Q3
$384K Buy
2,317
+78
+3% +$17.2K ﹤0.01% 1256
2015
Q2
$540K Buy
2,239
+251
+13% +$66.8K ﹤0.01% 1222
2015
Q1
$561K Hold
1,988
﹤0.01% 1226
2014
Q4
$310K Buy
1,988
+75
+4% +$13.9K ﹤0.01% 1349
2014
Q3
$453K Hold
1,913
﹤0.01% 1302
2014
Q2
$453K Sell
1,913
-4,197
-69% -$1.11M ﹤0.01% 1337
2014
Q1
$2.02M Buy
+6,110
New +$2.06M ﹤0.01% 1104

Other funds holding ICPT

American Century Companies's ICPT Position: Q1 2019 in Review

American Century Companies sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 27,057 shares — an estimated $2.73M sold.

American Century Companies first reported a position in ICPT in Q1 2014 and held it in 10 quarters. The position peaked at $3.73M in Q3 2018. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

  • American Century Companies reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • American Century Companies sold 27,057 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $2.73M.
  • American Century Companies first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
  • American Century Companies's Intercept Pharmaceuticals, Inc. position peaked at $3.73M in Q3 2018.
  • 202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on American Century Companies's 13F filing for Q1 2019, filed 14 May 2019.